Short-term outcomes after implementation of SABA-free asthma management with a maintenance and anti-inflammatory reliever regimen within primary care

Aim: Short-acting β2-agonist (SABA) overuse adversely affects asthma-related outcomes and the environment. The latest Global Initiative for Asthma (GINA) report no longer recommends SABA-only therapy. Since 2020, we have implemented an inhaled corticosteroid (ICS)-containing reliever strategy for ou...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Samantha Harrison, Emma Goulding, Julie Read, Sudip Ghosh
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Open Exploration Publishing Inc. 2025-01-01
Edice:	Exploration of Asthma & Allergy
Témata:	asthma inhaled corticosteroid (ics) short-acting β2-agonist (saba) ventolin exacerbation
On-line přístup:	https://www.explorationpub.com/uploads/Article/A100969/100969.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!